Evaluating Compliance with Quality Indicators of HIV and AIDS Clinical Care and Analyzing Those Associated with Mortality in the Democratic Republic of Congo

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2024 Nov 28

PMID 39609662

Authors

Tambwe Willy Muzumbukilwa

Bihehe Masemo Dieudonne

Riziki Ghislain Manimani

Aganze Gloire Mushebenge

Rajesh Vikram Vagiri

Manimbulu Nlooto

Affiliations

Soon will be listed here.

Abstract

Background: Since human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) infection have been identified, significant improvements have been made concerning its diagnosis and treatment. Few contributions have been made in the area of quality indicators in the Democratic Republic of Congo (DRC). To address this gap, a recent study conducted in the said area in 2023 resulted in the development of a comprehensive list of 88 indicators for assessing the quality of clinical care for HIV and AIDS. Out of these, 66 were identified as a core set of quality indicators for the assessment of HIV and AIDS clinical care. The aim of this study was to evaluate compliance with these quality indicators and determine those that are associated with mortality among people living with HIV and AIDS (PLWHA) in the DRC.

Methods: A retrospective cohort study was conducted at Panzi Hospital in Bukavu, South Kivu province of the DRC. The study population included PLWHA adult patients who were followed for a period of five years at the antiretroviral (ARV) clinic from January 2017 to December 2021. Descriptive analysis was performed to evaluate essential characteristics, and inferential statistics were performed including a multivariable logistic regression analysis performed to assess the association between selected clinical care indicators and PLWHA mortality, to estimate the odds ratios of mortality based on various factors, and to control for confounding variables.

Results: A total of 884 PLWHA were included. The level of compliance with the quality indicators was 78.79%. In the multivariate analysis, the quality-of-care indicators associated with mortality in the follow-up PLWHA on treatment were items 12 (Late diagnosis of HIV infection in specialized care), 24 (Assessment of resistance in cases of virologic failure), and 38 (Evaluation of Cardiac risk). Other factors associated with mortality were male sex, lower CD4 (< 500mm) and high viral load (> 50 copies/ml).

Conclusion: The level of compliance with the indicators was moderate. Some quality indicators were associated with mortality. These indicators are associated with delayed diagnosis of HIV infection, assessment of resistances in case of virologic failure, and evaluation of cardiac risk. Addressing gaps in adherence to these quality of care indicators (clinical care standards) could potentially reduce mortality rates and enhance the overall management of HIV and AIDS, particularly at Panzi Hospital in Bukavu, South Kivu Province, and in general in the DRC.

References

Tran B, Vu G, Ha G, Phan H, Latkin C, H-Ho C . Global Mapping of Interventions to Improve the Quality of Life of People Living with HIV/AIDS: Implications for Priority Settings. AIDS Rev. 2020; 23(3):91-102. DOI: 10.24875/AIDSRev.20000135. View

So-Armah K, Benjamin L, Bloomfield G, Feinstein M, Hsue P, Njuguna B . HIV and cardiovascular disease. Lancet HIV. 2020; 7(4):e279-e293. PMC: 9346572. DOI: 10.1016/S2352-3018(20)30036-9. View

Vos A, Dodd C, Delemarre E, Nierkens S, Serenata C, Grobbee D . Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk. Front Immunol. 2021; 12:647805. PMC: 8287326. DOI: 10.3389/fimmu.2021.647805. View

Belay Y, Yitayal M, Atnafu A, Taye F . Barriers and facilitators to the implementation and scale up of differentiated service delivery models for HIV treatment in Africa: a scoping review. BMC Health Serv Res. 2022; 22(1):1431. PMC: 9703668. DOI: 10.1186/s12913-022-08825-2. View

Ha J, Van Lith L, Mallalieu E, Chidassicua J, Pinho M, Devos P . Gendered relationship between HIV stigma and HIV testing among men and women in Mozambique: a cross-sectional study to inform a stigma reduction and male-targeted HIV testing intervention. BMJ Open. 2019; 9(10):e029748. PMC: 6797434. DOI: 10.1136/bmjopen-2019-029748. View

Gabre M, Tafesse T, Geleta L, Asfaw C, Delelegn H . The effect of late presentation on HIV related mortality among adolescents in public hospitals of north showa zone Oromiya, Ethiopia; 2022: a retrospective cohort study. BMC Infect Dis. 2024; 24(1):644. PMC: 11209987. DOI: 10.1186/s12879-024-09550-3. View

Lilian R, Rees K, McIntyre J, Struthers H, Peters R . Same-day antiretroviral therapy initiation for HIV-infected adults in South Africa: Analysis of routine data. PLoS One. 2020; 15(1):e0227572. PMC: 6959580. DOI: 10.1371/journal.pone.0227572. View

Crepaz N, Song R, Lyss S, Hall H . Estimated time from HIV infection to diagnosis and diagnosis to first viral suppression during 2014-2018. AIDS. 2021; 35(13):2181-2190. PMC: 9647140. DOI: 10.1097/QAD.0000000000003008. View

Johnson L, Dorrington R, Moolla H . Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa. South Afr J HIV Med. 2018; 18(1):694. PMC: 5843157. DOI: 10.4102/sajhivmed.v18i1.694. View

10.

Chapman K, Machado S, van der Merwe K, Bryson A, Smith D . Exploring Primary Care Non-Attendance: A Study of Low-Income Patients. J Prim Care Community Health. 2022; 13:21501319221082352. PMC: 8918768. DOI: 10.1177/21501319221082352. View

11.

Scheibe A, Young K, Versfeld A, Spearman C, Sonderup M, Prabdial-Sing N . Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017). BMC Infect Dis. 2020; 20(1):655. PMC: 7475946. DOI: 10.1186/s12879-020-05359-y. View

12.

Touloumi G, Kalpourtzi N, Papastamopoulos V, Paparizos V, Adamis G, Antoniadou A . Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece. PLoS One. 2020; 15(3):e0230730. PMC: 7105103. DOI: 10.1371/journal.pone.0230730. View

13.

Beaulieu N, Dafny L, Landon B, Dalton J, Kuye I, McWilliams J . Changes in Quality of Care after Hospital Mergers and Acquisitions. N Engl J Med. 2020; 382(1):51-59. PMC: 7080214. DOI: 10.1056/NEJMsa1901383. View

14.

Bakewell N, Kanitkar T, Dissanayake O, Symonds M, Rimmer S, Adlakha A . Estimating the risk of mortality attributable to recent late HIV diagnosis following admission to the intensive care unit: A single-centre observational cohort study. HIV Med. 2022; 23(11):1163-1172. PMC: 10099479. DOI: 10.1111/hiv.13436. View

15.

Gesicho M, Were M, Babic A . Evaluating performance of health care facilities at meeting HIV-indicator reporting requirements in Kenya: an application of K-means clustering algorithm. BMC Med Inform Decis Mak. 2021; 21(1):6. PMC: 7789797. DOI: 10.1186/s12911-020-01367-9. View

16.

Rasella D, Hone T, de Souza L, Tasca R, Basu S, Millett C . Mortality associated with alternative primary healthcare policies: a nationwide microsimulation modelling study in Brazil. BMC Med. 2019; 17(1):82. PMC: 6485171. DOI: 10.1186/s12916-019-1316-7. View

17.

Opoku S, Sakyi S, Ayisi-Boateng N, Enimil A, Senu E, Ansah R . Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana. AIDS Res Ther. 2022; 19(1):21. PMC: 9131580. DOI: 10.1186/s12981-022-00447-2. View

18.

Gimeno-Garcia A, Franco-Moreno A, Montero-Hernandez C, Arponen S, Garcia-Carrasco E, Alejos B . Analysis of adherence to HIV-positive quality of care indicators and their impact on service quality perceptions in patients: a Spanish cross-sectional study. Health Qual Life Outcomes. 2020; 18(1):185. PMC: 7294604. DOI: 10.1186/s12955-020-01441-w. View

19.

Bisson G, Bastos M, Campbell J, Bang D, Brust J, Isaakidis P . Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis. Lancet. 2020; 396(10248):402-411. PMC: 8094110. DOI: 10.1016/S0140-6736(20)31316-7. View

20.

Kharsany A, Cawood C, Lewis L, Yende-Zuma N, Khanyile D, Puren A . Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa. JAMA Netw Open. 2019; 2(11):e1914378. PMC: 6826647. DOI: 10.1001/jamanetworkopen.2019.14378. View